Related Experiment Video
Updated: Oct 16, 2025

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
The prognostic role of D-dimer in hospitalized COVID-19 patients
Insights
Elevated D-dimer levels in COVID-19 patients are linked to increased mortality risk. A D-dimer measurement of ≥0.5 indicated a 7.3-fold higher risk of death in hospitalized SARS-CoV-2 patients.
Area of Science:
- Medical Research
- Clinical Diagnostics
- Epidemiology
Background:
- Assessing prognosis in COVID-19 patients is crucial.
- Understanding the link between D-dimer levels and COVID-19 outcomes is important for early disease management.
Purpose of the Study:
- To investigate the prognostic significance of D-dimer levels in hospitalized COVID-19 patients.
- To determine if D-dimer levels can predict mortality in SARS-CoV-2 infection.
Main Methods:
- A cohort study of 1,669 laboratory-confirmed COVID-19 patients hospitalized between March 11 and April 20, 2020.
- Exclusion of patients with conditions that could elevate D-dimer.
- Logistic regression analysis to evaluate the impact of D-dimer, CRP, ferritin, and troponin on mortality.
Main Results:
- D-dimer levels were significantly higher in non-surviving patients.
- A D-dimer measurement ≥0.5 was associated with a 7.325-fold increased risk of mortality.
- The logistic regression model explained 91.3% of the variance in mortality.
Conclusions:
- D-dimer is an independent risk factor for mortality in COVID-19 patients.
- Early D-dimer testing can aid in risk stratification and prognosis assessment for SARS-CoV-2 patients.
Introduction:
In COVID-19 patients, the determination of the relationship between elevated D-dimer level and prognosis and the determination of thrombosis formation in the early stages of the disease are very important. The aim of this study was to investigate the prognostic role of D-dimer levels based on presentation in patients hospitalized with the diagnosis of COVID-19.
Method:
The study was conducted on patients hospitalized with the diagnosis of laboratory-confirmed COVID-19 between March 11 and April 20, 2020. Patients with diseases that could have caused an increase in D-dimer were excluded from the study.
Results:
The evaluation was made across a total of 1,669 patients, comprising 782 (46.9 %) females and 887 (53.1 %) males. The effects of D-dimer, CRP, ferritin, and troponin on mortality were evaluated with Enter Logistic Regression Analysis, and the model was found to be significant, with an explanatory coefficient of the model at a very good level of 91.3 %. The D-dimer scores were determined to be higher in patients who did not survive. The risk of mortality was seen to be 7.325-fold higher in cases with D-dimer measurement ≥0.5.
Conclusion:
The study results showed that the D-dimer test was an independent risk factor showing mortality in COVID-19 patients (Tab. 6, Ref. 27). Text in PDF www.elis.sk Keywords: D-dimer, SARS-CoV-2, mortality.
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism III: Nursing Management
Acute Coronary Syndrome III: Diagnostic Studies
Pulmonary Embolism I: Introduction

